Skip to main content
. 2006 Dec 28;51(3):845–851. doi: 10.1128/AAC.01051-06

TABLE 3.

Effect of four-times-daily treatmenta with T-705 or oseltamivir on an infection in mice induced by influenza A/Duck/MN/1525/81 (H5N1) virus

Expt no. and treatmenta Dose (mg/kg/day) Infected, treated miceg
Toxicity controls
No. of survivors/total no. tested MDDb ± SD Day 1 mean lung virus titerc ± SD Day 6 mean lung scored ± SD Day 6 mean lung wt (mg) ± SD Mean day 11 SaO2 (%) ± SD No. of survivors/total no. tested following rechallengee No. of survivors/total no. tested Mean host wt changef (g)
Expt 1
    T-705 300 10/10*** >21.0*** 3.5 ± 0.8*** 0.3 ± 0.3* 146 ± 12*** 88.6 ± 3.8*** 10/10 3/3 0.6
    T-705 100 10/10*** >21.0*** 4.9 ± 0.3** 0.5 ± 0.0* 140 ± 20*** 85.9 ± 5.9*** 10/10 3/3 1.1
    T-705 33 10/10*** >21.0*** 5.8 ± 0.5 1.3 ± 0.3* 217 ± 6** 84.8 ± 4.8*** 10/10 3/3 0.2
    Oseltamivir 20 2/10 9.4 ± 1.2*** 6.1 ± 0.5 2.2 ± 0.6* 270 ± 36* 76.9 ± 3.8* 0/2 3/3 0.6
    CMC 0/20 6.6 ± 1.1 6.3 ± 0.4 3.3 ± 0.3 360 ± 42 75.0 ± 0.0
    Healthy controls 0.0 ± 0.0 0.0 ± 0.0 117 ± 21 92.6 ± 3.5 0/5 3/3 0.8
Expt 2
    T-705 300 9/9*** >21.0*** 2.4 ± 0.4*** 0.5 ± 0.0* 123 ± 15*** 85.9 ± 6.9*** 9/9 3/3 0.0
    T-705 100 10/10*** >21.0*** 5.3 ± 0.3** 0.7 ± 0.3* 153 ± 15*** 84.6 ± 4.4*** 10/10 3/3 −0.1
    T-705 33 9/10*** 12.0 ± 0.0 5.8 ± 0.4 1.7 ± 0.6* 173 ± 6*** 81.6 ± 6.3*** 9/9 3/3 0.0
    Oseltamivir 20 1/10 9.3 ± 1.7*** 6.3 ± 0.1 3.5 ± 0.0 247 ± 23** 76.6 ± 3.9 1/1 3/3 0.2
    CMC 0/20 6.1 ± 0.8 6.4 ± 0.4 3.6 ± 0.2 328 ± 13 75.0 ± 0.0
    Healthy controls 5/5 >21.0 0.0 ± 0.0 0.0 ± 0.0 117 ± 6 93.2 ± 2.8 0/5 3/3 1.3
a

The doses were administered every 6 h for 5 days beginning 1 h after virus exposure (oseltamivir was given twice daily for 5 days beginning 1 h after virus exposure).

b

MDD, mean day to death of mice dying prior to day 21.

c

Log10 CCID50/g.

d

Plum coloration of lung ranging from 0 (normal lung) to 4 (maximal coloration).

e

Rechallenged with 100-fold more virus on day 21.

f

Difference between initial weight and weight 18 h after final treatment.

g

*, P < 0.05 compared to the results for the CMC-treated controls; **, P < 0.01 compared to the results for the CMC-treated controls; ***, P < 0.001 compared to the results for the CMC-treated controls.